On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Vasoactive peptides
- Specific characteristics of the BBB
- Angiotensins
- Effects of angiotensin II
- Angiotensins and the BBB
- Effects of other angiotensins
- Angiotensinogen-deficient mice
- BBB and renin-angiotensin system
- Bradykinin
- Effects of bradykinin
- B2 agonist transiently opens the BBB
- Calcitonin peptide superfamily
- Heterodimeric receptors for CGRP and AM
- Adrenomedullin
- Primary cultures of the BBB cells
- Adrenomedullin production
- BBB model based on cell culture
- Astrocytes induce AM secretion from CEC
- AM concentration in the cerebral circulation
- AM acts mostly in autocrine or paracrine manner
- AM increases intracellular cAMP level in CEC
- AM increases TEER in brain endothelial cells
- Effect of chronic AM treatment on TEER
- Effects of AM on cerebral endothelial permeability
- AM activates P-glycoprotein efflux pump in CEC
- AM protects against oxidative damage in CEC
- Summary: AM and the BBB
- AM and the BBB model
- AM regulates endothelial permeability
- Calcitonin-gene related peptide
- CGRP overexpression in brain
- CGRP and the BBB
- Endothelins family
- The effects of endothelins
- Endothelins and the BBB
- Endothelins and BBB efflux pumps
- Natriuretic peptides (NPs)
- The effects of natriuretic peptides
- Natriuretic peptides and the BBB
- Pituitary adenylate cyclase activating peptide
- Effects of PACAP
- PACAP increases tightness of the barrier in CEC
- Substance P
- Effects of substance P
- Substance P and the BBB
- Urotensin
- Vasopressin
- Effects of vasopressin
- AVP stimulates the BBB Na-K-Cl cotransport
- Summary
- Acknowledgements
Topics Covered
- Blood-brain-barrier (BBB) functions, permeability pathways and transporters modulated by vasoactive peptides
- The BBB as a source and target of vasocative peptides
- Angiotensins
- Bradykinin
- Adrenomedullin
- Calcitonin-gene related peptide
- Endothelins
- Natriuretic peptides
- Pituitary adenylate cyclase activating peptide
- Substance P
- Urotensin
- Vasopressin
- Potential use of vasocative peptides as modulators of BBB functions
Talk Citation
Deli, M. and Kis, B. (2008, March 1). Vasoactive peptides and the blood-brain barrier [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/NXAG7944.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Maria Deli has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
- Prof. Bela Kis has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.